Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SYED S MUSTAFA

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1619023223
CMS profile
27964
Location
ROCHESTER, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$144,119.36

123 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SYED S MUSTAFA

NPI 1619023223 · CMS profile ID 27964

Allopathic & Osteopathic Physicians / Allergy & Immunology

ROCHESTER, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1619023223?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SYED S MUSTAFA, NPI 1619023223, CMS profile ID 27964. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1619023223?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SYED S MUSTAFA, NPI 1619023223, CMS profile ID 27964. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1619023223?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SYED S MUSTAFA, NPI 1619023223, CMS profile ID 27964, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1619023223?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

123 matching records · $144,119.36 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 123 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 123.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $1,625.0007/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116103185 CMS
AstraZeneca Pharmaceuticals LP $250.0007/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105488715 CMS
kaleo, Inc. $13.3807/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126630756 CMS
AstraZeneca Pharmaceuticals LP $250.0007/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104418145 CMS
GlaxoSmithKline, LLC. $3,900.0007/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116361443 CMS
AstraZeneca Pharmaceuticals LP $2,150.0006/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104462594 CMS
AstraZeneca Pharmaceuticals LP $130.9406/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105591016 CMS
Novartis Pharmaceuticals Corporation $83.1406/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087116188 CMS
GENZYME CORPORATION $1,750.0006/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792295 CMS
GlaxoSmithKline, LLC. $1,214.1306/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116439625 CMS
GlaxoSmithKline, LLC. $115.2006/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116712629 CMS
Genentech USA, Inc. $1,800.0006/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133120877 CMS
Regeneron Healthcare Solutions, Inc. $949.5005/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114121069 CMS
GlaxoSmithKline, LLC. $3,900.0005/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116154741 CMS
AstraZeneca Pharmaceuticals LP $2,150.0005/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104467982 CMS
GlaxoSmithKline, LLC. $123.3905/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116207079 CMS
GlaxoSmithKline, LLC. $4.2905/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116363581 CMS
CSL Behring $3,900.0005/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134608659 CMS
CSL Behring $93.8005/10/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134608661 CMS
AstraZeneca Pharmaceuticals LP $109.9905/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104487968 CMS
AstraZeneca Pharmaceuticals LP $1,050.0005/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104693318 CMS
CSL Behring $124.9905/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134608657 CMS
GENZYME CORPORATION $2,216.0004/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792287 CMS
GENZYME CORPORATION $46.7004/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792283 CMS
GENZYME CORPORATION $3,482.0004/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792285 CMS
GENZYME CORPORATION $103.9104/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792275 CMS
GENZYME CORPORATION $6,647.0004/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792277 CMS
GENZYME CORPORATION $243.8004/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792279 CMS
GENZYME CORPORATION $2,844.6304/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792281 CMS
Grifols USA, LLC $109.2304/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124735785 CMS
GENZYME CORPORATION $121.6004/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792289 CMS
GENZYME CORPORATION $3,482.0004/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139792291 CMS
GlaxoSmithKline, LLC. $3.5004/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116720604 CMS
GlaxoSmithKline, LLC. $107.2004/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116485265 CMS
Regeneron Healthcare Solutions, Inc. $2,215.5004/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114121067 CMS
Regeneron Healthcare Solutions, Inc. $5,381.0004/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114121065 CMS
AstraZeneca Pharmaceuticals LP $1,074.0004/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105722813 CMS
GlaxoSmithKline, LLC. $3,900.0004/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116091313 CMS
Regeneron Healthcare Solutions, Inc. $124.9903/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114121063 CMS
GlaxoSmithKline, LLC. $1,300.0003/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115979271 CMS
Genentech USA, Inc. $124.2303/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133120874 CMS
AstraZeneca Pharmaceuticals LP $2,148.0003/25/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104688440 CMS
AstraZeneca Pharmaceuticals LP $3,200.0003/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105484093 CMS
AstraZeneca Pharmaceuticals LP $114.2903/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105832057 CMS
AstraZeneca Pharmaceuticals LP $93.8003/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105901124 CMS
AstraZeneca Pharmaceuticals LP $59.6803/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104591854 CMS
GlaxoSmithKline, LLC. $108.8003/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116719645 CMS
CSL Behring $1,500.0003/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134608655 CMS
AstraZeneca Pharmaceuticals LP $600.0003/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104548254 CMS
AstraZeneca Pharmaceuticals LP $2,150.0003/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104588042 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $97,501.80 98
PY2020 $65,309.56 84
PY2021 $157,864.47 122
PY2022 $133,506.89 113
PY2023 $159,603.62 126
PY2024 $144,119.36 123
PY2025 $190,494.45 179

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $210,898.02 18
PY2024 Recipient $9,055.37 6
PY2024 Principal investigator $477,242.15 41
PY2023 Recipient $6,781.27 9
PY2023 Principal investigator $488,088.13 44
PY2022 Principal investigator $41,743.91 7
PY2021 Principal investigator $2,500.00 1
PY2020 Principal investigator $120,272.15 6
PY2019 Principal investigator $1,359,819.28 26

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

18 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 11/17/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184261627
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 11/17/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184261629
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 11/17/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184261631
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 10/03/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184246259
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $96,554.16 07/23/2025 Non-covered Recipient Entity
RRH ALLERGY AND RHEUMATOLOGY ALEXANDER PARK
IISR-2020-103276 PREVALENCE OF HUMORAL IMMUNE DEFICIENCY IN PATIENTS WITH COPD, AND THE EFFECT OF IMMUNOGLOBULIN REPLACEMENT ON FUTURE EXACERBATIONS No dispute reported 06/30/2026 1223283070
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 06/18/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207929
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 06/18/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207931
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 06/18/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207933
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 06/18/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207935
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 05/19/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184196547
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 05/19/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184196549
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 02/27/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184156152
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $262.74 02/27/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184156154
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $262.74 02/27/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184156156
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 02/27/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184156158
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $262.74 02/27/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184156160
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $726.58 02/05/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152412
Principal investigator 1 AstraZeneca UK Limited $104,110.10 01/13/2025 Non-covered Recipient Entity
ROCHESTER GENERAL HOSPITAL
A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment No dispute reported 06/30/2026 1185554118